As pharmaceutical companies rapidly expand direct-to-consumer (DTC) models amid shifting US drug pricing reforms and the upcoming launch of TrumpRx, experts warn that these approaches introduce as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback